Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia
Fatemeh Ranjbar,1 Homayoun Sadeghi-Bazargani,2,3 Parisa Niari Khams,1 Asghar Arfaie,1 Azim Salari,4 Mostafa Farahbakhsh1 1Clinical Psychiatry Research Center, Tabriz University of Medical Sciences, Tabriz, East Azerbaijan, Iran; 2Road Traffic Injury Research Center, Department of Statistics &a...
Saved in:
| Main Authors: | Ranjbar F, Sadeghi-Bazargani H, Niari Khams P, Arfaie A, Salari A, Farahbakhsh M |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Dove Medical Press
2015
|
| Subjects: | |
| Online Access: | https://doaj.org/article/837f8cda400a4b578e65373c69c91c78 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hyperprolactinemia in Thai children and adolescents with autism spectrum disorder treated with risperidone
by: Hongkaew Y, et al.
Published: (2015) -
Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers
by: Ishioka M, et al.
Published: (2015) -
Risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study
by: Gabriel A
Published: (2013) -
Gabapentin adjunctive to risperidone or olanzapine in partially responsive schizophrenia: an open-label pilot study
by: Adel Gabriel
Published: (2010) -
Treatment and prevention of mania in bipolar I disorder: focus on aripiprazole
by: David J Muzina
Published: (2009)